| Esophageal Cancer Research and Treatment | Lifetime | 11 | JP 1 | 99.79 |
| Gastric Cancer Management and Outcomes | Lifetime | 31 | JP 6 | 99.84 |
| Metastasis and carcinoma case studies | Lifetime | 20 | JP 14 | 99.58 |
| Esophageal and GI Pathology | Lifetime | 72 | JP 3 | 99.63 |
| Gastrointestinal Tumor Research and Treatment | Lifetime | 66 | JP 18 | 99.51 |
| Pancreatic and Hepatic Oncology Research | Lifetime | 237 | JP 25 | 99.28 |
| Cancer Immunotherapy and Biomarkers | Lifetime | 472 | JP 12 | 98.93 |
| Cancer-related molecular mechanisms research | Lifetime | 715 | JP 28 | 98.02 |
| MicroRNA in disease regulation | Lifetime | 690 | JP 27 | 97.90 |
| Lung Cancer Diagnosis and Treatment | Lifetime | 564 | JP 61 | 98.53 |
| Colorectal Cancer Surgical Treatments | Lifetime | 413 | JP 39 | 98.04 |
| Cancer Cells and Metastasis | Lifetime | 550 | JP 22 | 97.72 |
| Cancer-related gene regulation | Lifetime | 572 | JP 56 | 97.34 |
| Cancer-related Molecular Pathways | Lifetime | 667 | JP 30 | 97.77 |
| Cholangiocarcinoma and Gallbladder Cancer Studies | Lifetime | 702 | JP 151 | 97.43 |
| Colorectal and Anal Carcinomas | Lifetime | 518 | JP 36 | 96.99 |
| Wnt/β-catenin signaling in development and cancer | Lifetime | 370 | JP 33 | 95.96 |
| Ferroptosis and cancer prognosis | Lifetime | 759 | JP 19 | 93.51 |
| Inflammatory Biomarkers in Disease Prognosis | Lifetime | 583 | JP 97 | 91.44 |
| Kruppel-like factors research | Lifetime | 493 | JP 48 | 91.72 |
| Minimally Invasive Surgical Techniques | Lifetime | 450 | JP 18 | 92.28 |
| Enhanced Recovery After Surgery | Lifetime | 936 | JP 47 | 87.27 |
| FOXO transcription factor regulation | Lifetime | 889 | JP 60 | 74.79 |
| Clusterin in disease pathology | Lifetime | 438 | JP 31 | 64.78 |
| Esophageal Cancer Research and Treatment | 2021-2025 | 5 | JP 3 | 99.82 |
| Metastasis and carcinoma case studies | 2021-2025 | 2 | JP 1 | 99.43 |
| Gastric Cancer Management and Outcomes | 2021-2025 | 16 | JP 4 | 99.77 |
| Esophageal and GI Pathology | 2021-2025 | 29 | JP 7 | 99.17 |
| Gastrointestinal Tumor Research and Treatment | 2021-2025 | 28 | JP 5 | 99.02 |
| Pancreatic and Hepatic Oncology Research | 2021-2025 | 191 | JP 17 | 98.14 |
| Cancer Immunotherapy and Biomarkers | 2021-2025 | 314 | JP 10 | 98.78 |
| Colorectal Cancer Surgical Treatments | 2021-2025 | 441 | JP 62 | 93.52 |
| Enhanced Recovery After Surgery | 2021-2025 | 760 | JP 28 | 68.84 |
| Stoma care and complications | 2021-2025 | 453 | JP 31 | 65.03 |
| Abdominal Surgery and Complications | 2021-2025 | 585 | JP 8 | 61.78 |
| Cancer, Stress, Anesthesia, and Immune Response | 2021-2025 | 810 | JP 32 | 59.99 |
| Clusterin in disease pathology | 2021-2025 | 170 | JP 34 | 29.16 |
| Hemostasis and retained surgical items | 2021-2025 | 988 | JP 45 | 16.29 |
